Clinical Trial: Induction Chemo-Nivo in Unresectable Stage III NSCLC
Study Status: Completed
Recruit Status: RECRUITING
Condition: Lung Cancer, Nonsmall Cell
Study Type: INTERVENTIONAL
Official Title: Phase II Study of Induction Platinum Doublet in Combination With Nivolumab Followed by Surgery or Concurrent Chemoradiation in Unresectable Stage IIIA-C Non-small Cell Lung Cancer (NSCLC)
Brief Summary:
The purpose of this study is to determine the response rate, safety, and effectiveness of a combination therapy in patients with lung cancer.
Read more